首页> 外文期刊>British Journal of Obstetrics and Gynaecology >Influence of chemotherapy for gestational trophoblastic disease on subsequent pregnancy outcome.
【24h】

Influence of chemotherapy for gestational trophoblastic disease on subsequent pregnancy outcome.

机译:妊娠滋养细胞疾病的化学疗法对随后妊娠结局的影响。

获取原文
获取原文并翻译 | 示例
           

摘要

The aim of this study was to determine the influence of cytotoxic chemotherapy on subsequent reproductive performance. Details of post-treatment reproductive intent and outcome were requested from 1211 survivors registered at The Charing Cross Hospital gestational trophoblastic disease centre; a response rate of 96% was achieved. Seven hundred and twenty-eight women had tried to become pregnant; 607 reported at least one live birth, 73 conceived but had not registered a live birth, and 48 did not conceive. No differences were apparent between the 392 women who received methotrexate as single agent chemotherapy and the 336 treated with multi-agent chemotherapy. Women who had registered a live birth were younger (P < 0.0001) and the duration of follow up was significantly less among those who did not achieve pregnancy at all (P < 0.0003). A higher than expected rate of caesarean section and stillbirth was recorded. The chemotherapy protocols used by this unit have minimal impact on the subsequent ability to reproduce.
机译:这项研究的目的是确定细胞毒性化学疗法对随后的生殖性能的影响。向在查令十字医院妊娠滋养细胞疾病中心登记的1211名幸存者要求提供治疗后生殖意图和结果的详细信息;响应率为96%。 728名妇女试图怀孕。 607人报告至少有一个活产,73人受孕但未进行活产登记,48人未受孕。在接受甲氨蝶呤单药化疗的392名妇女与多药化疗的336名妇女之间没有明显差异。完全活产的妇女较年轻(P <0.0001),而完全没有怀孕的妇女的随访时间显着减少(P <0.0003)。剖腹产和死产的发生率高于预期。该单元使用的化学疗法方案对随后的繁殖能力影响很小。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号